Mario Picozza

Also affiliated with Fondazione Santa Lucia

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro‐adipogenic progenitors”.

Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro‐adipogenic progenitors

EMBO Reports(2022)10.15252/embr.202254721

N/A

0.760DataRank · unranked

22 citations

Luca Tucciarone, Elisa Macrì, Marco De Bardi, Mario Picozza, Illari Salvatori +6 more

Zinc and COVID-19: Basis of Current Clinical Trials

Biological Trace Element Research(2020)10.1007/s12011-020-02437-9

N/A

0DataRank · unranked

171 citations

Rosanna Squitti, Mario Picozza, Anil Pawar, Mauro Rongioletti, Atanu Kumar Dutta +5 more

The Nucleolar Protein Nucleophosmin Is Physiologically Secreted by Endothelial Cells in Response to Stress Exerting Proangiogenic Activity Both In Vitro and In Vivo

International Journal of Molecular Sciences(2021)10.3390/ijms22073672

N/A

0DataRank · unranked

10 citations

Sara Beji, Silvia Palmerio, Mario Picozza, M D'agostino, Vincenzo Petrozza +6 more

Partial resistance to HDAC inhibitors in FAPs of dystrophic muscles at late stages of disease is associated to epigenetic and transcriptional features of cellular senescence

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.26.441412

N/A

0DataRank · unranked

2 citations

Luca Tucciarone, Ettore Macrì, Marco De Bardi, Mario Picozza, Illari Salvatori +6 more